Los Angeles Firm Pelage Pharmaceuticals Raises $120 Million Series B Round for Hair Growth Treatment
Los Angeles biotech firm Pelage Pharmaceuticals raises a $120 million Series B round co-led by ARCH Venture Partners and ...
Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.
Yeast doesn’t know it’s making humanity’s favorite molecule. In this episode, we explore how chemistry turns fruit juice into ...
Ever wondered what “artificial vanilla” actually means? In this episode, we take vanilla extract to chemistry class, chase ...
The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems ...
Experts weigh in on whether at-home micro-current devices live up to their claims. Discover which tools actually sculpt, lift ...
MT-125, a dual small-molecule inhibitor, received FDA fast track designation for glioblastoma, facilitating expedited drug ...
The Print on MSN
Roche patent case: Why SC refused to halt Natco’s generic spinal muscular atrophy drug Risdiplam
Roche had approached Delhi High Court, accusing Natco of violating its Indian patent, before going to the Supreme Court with ...
Football365 on MSN
Liverpool in ‘transition season’ as VVD ‘declines into Lovren’; Man Utd ‘hope cannot be allowed to fester’
Liverpool are 'absolute s****' and now in a 'transition season' as Virgil van Dijk and Mohamed Salah are heavily criticised ...
For Missouri residents, having Lambert’s in your state is something of a point of pride – a quirky cultural institution that puts Sikeston on the map. For visitors, it becomes a mandatory stop on any ...
ONL Therapeutics announced the first patient has been randomized in its phase 2 GALAXY ( NCT06659445) trial evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results